GLI2-Specific Transcriptional Activation of the Bone Morphogenetic Protein/Activin Antagonist Follistatin in Human Epidermal Cells
March 2008
in “
Journal of biological chemistry/The Journal of biological chemistry
”
New to Follistatin? There is a guide in the encyclopedia. Read the guide →
Studysummary This study found that GLI2 plays a key role in activating follistatin, an activin/BMP antagonist, in response to hedgehog signaling in human epidermal cells, with implications for hair follicle development and basal cell carcinoma. Our plain-language summary of this paper — not a Tressless recommendation.
The study demonstrated that in human epidermal cells, the expression of the activin/BMP antagonist follistatin (FST) was predominantly up-regulated by the Hedgehog (HH) signaling effector GLI2. This up-regulation was specific to GLI2, as neither GLI1 nor GLI3 significantly increased FST transcription. The research identified two GLI consensus binding sites in the FST promoter necessary for GLI2-mediated activation, with a 518-bp fragment in the proximal promoter region being crucial for this specificity. Additionally, sequences C-terminal to the zinc finger in GLI2 were responsible for this specific activation, suggesting the involvement of GLI-interacting cofactors. The findings highlighted a significant role of GLI2 in the regulation of FST in response to HH signaling, indicating a regulatory interaction between HH and activin/BMP signaling pathways in hair follicle development and basal cell carcinoma (BCC).